FDA Inspection
Abaco Partners, LLCAbaco Partners, LLC – FDA Inspection, Nov 10, 2021
Record Details
This FDA Inspection record concerns Abaco Partners, LLC, with an inspection on November 10, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Abaco Partners, LLC
- Inspection Date
- November 10, 2021
- Product Type
- Drugs
View Company Profile
ID · b73fae78-0be3-44b4-8378-a4c90986a9cf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1156416
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.166(b)Accelerated stability studies
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Abaco Partners, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2026 | Not classified | Detroit District Office | |
| March 23, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Abaco Partners, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.